• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小窝介导的内吞作用驱动聚合物纳米颗粒向巨噬细胞的高效 siRNA 递送。

Caveolae-Mediated Endocytosis Drives Robust siRNA Delivery of Polymeric Nanoparticles to Macrophages.

机构信息

State Key Laboratory of Genetic Engineering, Department of Pharmaceutical Sciences, School of Life Sciences, Fudan University, Shanghai 200438, P.R. China.

State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200438, P.R. China.

出版信息

ACS Nano. 2021 May 25;15(5):8267-8282. doi: 10.1021/acsnano.0c08596. Epub 2021 Apr 29.

DOI:10.1021/acsnano.0c08596
PMID:33915044
Abstract

Cytosolic delivery of small interfering RNA (siRNA) remains challenging, and a profound understanding of the cellular uptake and intracellular processing of siRNA delivery systems could greatly improve the development of siRNA-based therapeutics. Here, we show that caveolae-mediated endocytosis (CvME) accounts for the robust siRNA delivery of mannose-modified trimethyl chitosan-cysteine/tripolyphosphate nanoparticles (MTC/TPP NPs) to macrophages by circumventing lysosomes. We show that the Golgi complex and ER are key organelles required for the efficient delivery of siRNA to macrophages in which the siRNA accumulation positively correlates with its silencing efficiency ( = 0.94). We also identify syntaxin6 and Niemann-Pick type C1 (NPC1) as indispensable regulators for MTC/TPP NPs-delivered siRNA into macrophages both and . Syntaxin6 and NPC1 knockout substantially decrease the cellular uptake and gene silencing of the siRNA delivered in MTC/TPP NPs in macrophages, which result in poor therapeutic outcomes for mice bearing acute hepatic injury. Our results suggest that highly efficient siRNA delivery can be achieved CvME, which would give ideas for designing optimal delivery vectors to facilitate the clinical translation of siRNA drugs.

摘要

细胞质内递送小干扰 RNA(siRNA)仍然具有挑战性,深入了解 siRNA 递送系统的细胞摄取和细胞内处理过程,可以极大地促进基于 siRNA 的治疗药物的发展。在这里,我们表明,笼形蛋白介导的内吞作用(CvME)通过绕过溶酶体,使甘露糖修饰的三甲基壳聚糖-半胱氨酸/三聚磷酸酯纳米粒(MTC/TPP NPs)能够有效地将 siRNA 递送至巨噬细胞。我们表明,高尔基体和内质网是将 siRNA 有效递送至巨噬细胞所必需的关键细胞器,其中 siRNA 的积累与沉默效率呈正相关(=0.94)。我们还发现,网格蛋白 6 和尼曼-匹克 C1(NPC1)是 MTC/TPP NPs 递送至巨噬细胞中 siRNA 的不可或缺的调节剂,无论是内吞作用还是胞吐作用。网格蛋白 6 和 NPC1 的敲除会显著降低巨噬细胞中 MTC/TPP NPs 递送的 siRNA 的细胞摄取和基因沉默,从而导致急性肝损伤小鼠的治疗效果不佳。我们的结果表明,可以通过 CvME 实现高效的 siRNA 递送,这为设计最佳递送载体以促进 siRNA 药物的临床转化提供了思路。

相似文献

1
Caveolae-Mediated Endocytosis Drives Robust siRNA Delivery of Polymeric Nanoparticles to Macrophages.小窝介导的内吞作用驱动聚合物纳米颗粒向巨噬细胞的高效 siRNA 递送。
ACS Nano. 2021 May 25;15(5):8267-8282. doi: 10.1021/acsnano.0c08596. Epub 2021 Apr 29.
2
Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.优化多功能壳聚糖-siRNA 纳米粒用于口服给药应用,靶向大鼠 TNF-α 沉默。
Acta Biomater. 2015 Apr;17:98-106. doi: 10.1016/j.actbio.2015.01.041. Epub 2015 Feb 7.
3
siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.聚合物纳米粒中 siRNA 的释放动力学与通过口服给药的 RNAi 效率和炎症治疗相关。
Acta Biomater. 2020 Feb;103:213-222. doi: 10.1016/j.actbio.2019.12.005. Epub 2019 Dec 6.
4
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.用于 TNF-α siRNA 口服递送至巨噬细胞的多功能聚合物纳米粒。
Biomaterials. 2013 Apr;34(11):2843-54. doi: 10.1016/j.biomaterials.2013.01.033. Epub 2013 Jan 21.
5
Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles.多糖密度对聚合物纳米粒体内外细胞摄取和 RNAi 效率的影响。
Biomaterials. 2015 Jun;52:229-39. doi: 10.1016/j.biomaterials.2015.02.044. Epub 2015 Feb 27.
6
Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages.半乳糖化三甲基壳聚糖-半胱氨酸纳米载体制备 Map4k4siRNA 靶向激活型巨噬细胞
Biomaterials. 2013 May;34(14):3667-77. doi: 10.1016/j.biomaterials.2013.01.079. Epub 2013 Feb 15.
7
Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy.甘露糖化生物还原性纳米颗粒介导的巨噬细胞特异性 TNF-α RNA 干扰治疗 IBD。
Biomaterials. 2013 Oct;34(30):7471-82. doi: 10.1016/j.biomaterials.2013.06.008. Epub 2013 Jun 29.
8
Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages.三聚磷酸钠对壳聚糖基纳米颗粒在Raw 264.7巨噬细胞中细胞摄取及RNA干扰效率的影响
J Colloid Interface Sci. 2017 Mar 15;490:520-528. doi: 10.1016/j.jcis.2016.11.088. Epub 2016 Nov 26.
9
Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.三甲基壳聚糖-半胱氨酸纳米粒经口服和腹腔途径系统递送达 TNF-α siRNA
Pharm Res. 2013 Oct;30(10):2596-606. doi: 10.1007/s11095-013-1086-4. Epub 2013 May 29.
10
Ternary polymeric nanoparticles for oral siRNA delivery.用于口服 siRNA 递送的三元聚合物纳米粒。
Pharm Res. 2013 May;30(5):1228-39. doi: 10.1007/s11095-012-0961-8. Epub 2013 Jan 10.

引用本文的文献

1
Tailorable bimetallic nanozyme mitigates intervertebral disc degeneration by inhibiting oxidative stress and inflammageing.可定制的双金属纳米酶通过抑制氧化应激和炎症衰老来减轻椎间盘退变。
Theranostics. 2025 Jun 9;15(14):6957-6982. doi: 10.7150/thno.108592. eCollection 2025.
2
Screening and Identification of Novel DNA Aptamer for Targeted Delivery to Injured Podocytes in Glomerular Diseases.用于靶向递送至肾小球疾病中损伤足细胞的新型DNA适配体的筛选与鉴定
Adv Sci (Weinh). 2025 May;12(20):e2412356. doi: 10.1002/advs.202412356. Epub 2025 Apr 3.
3
The Emerging Role of MicroRNAs in Nasal Inflammatory Diseases and Tumors: From Bench to Bedside.
微小RNA在鼻腔炎性疾病和肿瘤中的新兴作用:从实验台到临床应用
Genes (Basel). 2025 Feb 28;16(3):295. doi: 10.3390/genes16030295.
4
Combined Blockade of Lipid Uptake and Synthesis by CD36 Inhibitor and SCD1 siRNA Is Beneficial for the Treatment of Refractory Prostate Cancer.CD36抑制剂和SCD1小干扰RNA联合阻断脂质摄取与合成对难治性前列腺癌治疗有益。
Adv Sci (Weinh). 2025 Feb;12(8):e2412244. doi: 10.1002/advs.202412244. Epub 2024 Dec 30.
5
Effective delivery of miR-150-5p with nucleus pulposus cell-specific nanoparticles attenuates intervertebral disc degeneration.携带核髓细胞特异性纳米颗粒的 miR-150-5p 有效递呈可减轻椎间盘退变。
J Nanobiotechnology. 2024 May 27;22(1):292. doi: 10.1186/s12951-024-02561-x.
6
Nanozyme as a rising star for metabolic disease management.纳米酶:代谢疾病管理的新兴之星。
J Nanobiotechnology. 2024 May 6;22(1):226. doi: 10.1186/s12951-024-02478-5.
7
The application of plant-exosome-like nanovesicles as improved drug delivery systems for cancer vaccines.植物外泌体样纳米囊泡作为癌症疫苗改进型药物递送系统的应用。
Discov Oncol. 2024 Apr 29;15(1):136. doi: 10.1007/s12672-024-00974-6.
8
Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacy.靶向抗癌治疗:通过cRGD修饰的脂质纳米粒共递送血管内皮生长因子(VEGF)小干扰RNA(siRNA)和异硫氰酸苯乙酯(PEITC)以增强抗血管生成疗效
Asian J Pharm Sci. 2024 Apr;19(2):100891. doi: 10.1016/j.ajps.2024.100891. Epub 2024 Feb 23.
9
Bridging Smart Nanosystems with Clinically Relevant Models and Advanced Imaging for Precision Drug Delivery.将智能纳米系统与临床相关模型和先进成像技术相结合,实现精准药物输送。
Adv Sci (Weinh). 2024 Apr;11(14):e2308659. doi: 10.1002/advs.202308659. Epub 2024 Jan 28.
10
Biomimetic noncationic lipid nanoparticles for mRNA delivery.仿生非阳离子脂质纳米颗粒用于 mRNA 递送。
Proc Natl Acad Sci U S A. 2023 Dec 19;120(51):e2311276120. doi: 10.1073/pnas.2311276120. Epub 2023 Dec 11.